التفاصيل البيبلوغرافية
| العنوان: |
Eggerthella lenta bacteremia in solid tumor cancer patients: Pathogen or witness of frailty? |
| المؤلفون: |
Woerther, Paul-Louis1 paul-louis.woerther@aphp.fr, Antoun, Sami2, Chachaty, Elisabeth1, Merad, Mansouria2 |
| المصدر: |
Anaerobe. Oct2017, Vol. 47, p70-72. 3p. |
| مصطلحات موضوعية: |
*BACTEREMIA prevention, *BACTEREMIA treatment, *CANCER patients, *CLOSTRIDIA, *RHAMNOSE |
| مستخلص: |
Eggerthella lenta is increasingly found in patients with severe comorbidities. Because oncologic patients are exposed to emerging pathogens, we aimed to describe the factors associated with E. lenta bacteremia in this immunosuppressed population. Oncology patients with blood cultures positive for E. lenta were retrospectively recorded from 2009 to 2015. Socio-demographic and medical/biological data as well as potential risk factors and mortality were recorded and analyzed. Twenty-three patients were included. Gastro intestinal (GI) and gynecological cancers were reported in 12/23 (52%) and 7/23 cases (30%), respectively. Eleven/23 patients (48%) had metastatics lesions and 6/23 (26%) had peritoneal carcinomatosis. No associated tissue infection was found in 14/23 cases (61%). Blood cultures yielded at least one other species in addition to E. lenta in 10/23 cases (43%). Mortality associated with E. lenta bacteremia was 22% (5/23). E. lenta bacteremia often occurred in patients with advanced cancer disease without documented infection. In most of the cases, intestinal obstruction and/or isolated fever were the only recorded symptoms. In these cases, the damages of intestinal barrier induced by the cancer and/or its specific treatments may be the cause of bacterial translocation. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
